Trial Profile
Pharmacokinetics and safety of estradiol 10 microg/day versus 25 microg/day in postmenopausal patients with vaginal atrophy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2011
Price :
$35
*
At a glance
- Drugs Estradiol (Primary)
- Indications Atrophic vaginitis
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 09 Feb 2011 New trial record